Pfizer offloads $3.9 billion stake in Sensodyne-maker Haleon
(Reuters) – Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.9 billion stake in the consumer healthcare firm, bringing down its holding in the British company to 22.6%. Pfizer previously held a 32% stake, followed by second-largest shareholder GSK which has a 4.2% holding. WHY IT’S IMPORTANT This is Pfizer’s first stake sale …
Pfizer offloads $3.9 billion stake in Sensodyne-maker Haleon Read More »










